Summary
#LI-Onsite
Location: Cambridge, MA
About the role:
Novartis Oncology Biotherapeutics is seeking a passionate Scientist to advance biotherapeutic drug discovery for cancer. This role is perfect for a motivated individual with expertise in drug discovery for oncology, cancer immunology, or immunotherapy. Join our dynamic team and play a key role in developing treatments that impact patient lives!
About the Role
Key Responsibilities:
• Design and conduct in vitro assays to screen candidate immune cell-engaging (ICE) antibodies or biologics
• Analyze and interpret data to advance projects through the discovery pipeline.
• Explore and validate new drug targets
• Utilize automation and high-throughput systems for large-scale ICE antibody screening
• Document experimental results in electronic lab notebooks
• Present research findings in internal and external meetings
• Solve complex problems and optimize procedures to meet team goals
The pay range for this position at commencement of employment is expected to be between: Research Scientist II: $84,000- $126,000 / year | Senior Scientist I: $92,800 - $139,200 / year; however, while salary ranges are effective from 1/1/24 through 12/31/24, fluctuations in the job market may necessitate adjustments to pay ranges during this period. Further, final pay determinations will depend on various factors, including, but not limited to geographical location, experience level, knowledge, skills and abilities. The total compensation package for this position may also include other elements, including a sign-on bonus, restricted stock units, and discretionary awards in addition to a full range of medical, financial, and/or other benefits (including 401(k) eligibility and various paid time off benefits, such as vacation, sick time, and parental leave), dependent on the position offered. Details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base salary (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.
Novartis EVP Manifesto.mp4
Essential Requirements:
- This position will be located at the Cambridge, MA site and will not have the ability to be located remotely. This position will not require travel as defined by the business (domestic and/ or international). Novartis is unable to offer relocation support for this role. Please only apply if this location is accessible for you.
- Research Scientist II should have a bachelor's degree with 2-3 years of experience (industry or academia) or master's degree with 0-1 years (industry or academia) in cancer immunotherapy, cancer biology, molecular biology, or related fields
- Senior Scientist I should have a bachelor’s degree with 3-4 years (industry or academia) or master’s degree with 1-2 years (industry or academia) in cancer immunotherapy, cancer biology, molecular biology, or related fields
- Strong knowledge of immuno-oncology, immunology, or cell or molecular biology
- Hands-on experience with immune cell isolation, in vitro cell assays, and molecular techniques (e.g., cell line generation, MSD, RT-qPCR, lentiviral transduction, cell culture)
- Proficient in functional immune cell assays, including proliferation, phenotype profiling, cytokine profiling, or cytotoxicity assays
- Excellent documentation, data analysis, and presentation skills.
- Strong communication and teamwork abilities
Desirable Requirements:
- Industry experience in antibody or biologics drug discovery
- Experience with high-throughput instruments and multi-color flow cytometry
- Skills in lentiviral transduction and western blotting
- Experience with immune cell culture and assays
Commitment to Diversity and Inclusion / EEO paragraph:
Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each other. Combining to achieve breakthroughs that change patients’ lives. Ready to create a brighter future together? https://www.novartis.com/about/strategy/people-and-culture
Join our Novartis Network: Not the right Novartis role for you? Sign up to our talent community to stay connected and learn about suitable career opportunities as soon as they come up: https://talentnetwork.novartis.com/network
Benefits and Rewards: Read our handbook to learn about all the ways we’ll help you thrive personally and professionally: https://www.novartis.com/careers/benefits-rewards
EEO Statement:
The Novartis Group of Companies are Equal Opportunity Employers who are focused on building and advancing a culture of inclusion that values and celebrates individual differences, uniqueness, backgrounds and perspectives. We do not discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, sex, national origin, age, sexual orientation, gender identity or expression, marital or veteran status, disability, or any other legally protected status. We are committed to fostering a diverse and inclusive workplace that reflects the world around us and connects us to the patients, customers and communities we serve.
Accessibility & Reasonable Accommodations
The Novartis Group of Companies are committed to working with and providing reasonable accommodation to individuals with disabilities. If, because of a medical condition or disability, you need a reasonable accommodation for any part of the application process, or to perform the essential functions of a position, please send an e-mail to [email protected] or call +1(877)395-2339 and let us know the nature of your request and your contact information. Please include the job requisition number in your message.
